The Ordinary General Assembly June 16th 2021 elected Jan Alfheim as Regenics AS new Chairman of the Board. Jan is at present CEO of Oncoinvent AS. The other members of the Board were re-elected:
Tore Heldrup Rasmussen
Harald Nordal
Runhild Gammelsæter
New CEO:
On July 1st 2021 Henrik Lund stepped down as CEO to pursue other activities. Karl Bryn, MD has accepted the position as new CEO of Regenics AS, starting December 1st 2021.
For more info, see our team page or contact chairman Jan Alfheim.